Literature DB >> 21141732

The liver-specific microRNA miR-122: biology and therapeutic potential.

Witold Filipowicz1, Helge Grosshans.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that regulate the expression of a large fraction of genes in animals, plants, and protozoa. miRNA-mediated gene repression occurs posttranscriptionally, generally by base-pairing to the 3'-untranslated regions of target mRNAs, which inhibits protein synthesis and destabilizes the mRNA. In this chapter, we discuss the biological functions of miR-122, a highly abundant, liver-specific miRNA. We will review how studies of miR-122 helped to establish important new paradigms of miRNA-mediated regulation, as well as identifying miR-122 as a factor implicated in important human diseases, including cancer and hepatitis C. We discuss antisense strategies targeting miR-122 as a potential therapeutic approach to treat hepatitis C and possibly other diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21141732

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  31 in total

Review 1.  Bioactive Functions of Milk Proteins: a Comparative Genomics Approach.

Authors:  Julie A Sharp; Vengama Modepalli; Ashwanth Kumar Enjapoori; Swathi Bisana; Helen E Abud; Christophe Lefevre; Kevin R Nicholas
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-06-27       Impact factor: 2.673

2.  Inhibition of alpha interferon (IFN-α)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-α.

Authors:  Junli Hao; Wensong Jin; Xinghui Li; Saifeng Wang; Xiaojun Zhang; Hongxia Fan; Changfei Li; Lizhao Chen; Bin Gao; Guangze Liu; Songdong Meng
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

3.  MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication.

Authors:  Wen-Wen Chou; Chung-Feng Huang; Ming-Lun Yeh; Yi-Shan Tsai; Ming-Yen Hsieh; Ching-I Huang; Jee-Fu Huang; Pei-Chien Tsai; Edward Hsi; Suh-Hang Hank Juo; Wei-Lun Tsai; Wan-Long Chuang; Ming-Lung Yu; Chia-Yen Dai
Journal:  J Mol Med (Berl)       Date:  2015-10-21       Impact factor: 4.599

4.  Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver.

Authors:  John R Androsavich; B Nelson Chau; Balkrishen Bhat; Peter S Linsley; Nils G Walter
Journal:  RNA       Date:  2012-06-27       Impact factor: 4.942

5.  MiR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression.

Authors:  Guangzhi Wang; Yan Zhao; Yongri Zheng
Journal:  Tumour Biol       Date:  2014-05-27

6.  Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.

Authors:  Jin-Feng Huang; Hong-Yue Jiang; Hui Cai; Yan Liu; Yi-Qing Zhu; Sha-Sha Lin; Ting-Ting Hu; Tian-Tian Wang; Wen-Jun Yang; Bang Xiao; Shu-Han Sun; Li-Ye Ma; Hui-Rong Yin; Fang Wang
Journal:  Oncogene       Date:  2019-01-14       Impact factor: 9.867

Review 7.  Regulation of Luteinizing Hormone Receptor mRNA Expression in the Ovary: The Role of miR-122.

Authors:  K M J Menon; Bindu Menon; Thippeswamy Gulappa
Journal:  Vitam Horm       Date:  2018-02-19       Impact factor: 3.421

8.  Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion.

Authors:  Changfei Li; Yanzhong Wang; Saifeng Wang; Bo Wu; Junli Hao; Hongxia Fan; Ying Ju; Yuping Ding; Lizhao Chen; Xiaoyu Chu; Wenjun Liu; Xin Ye; Songdong Meng
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in Rats.

Authors:  Rachel J Church; Monicah Otieno; James Eric McDuffie; Bhanu Singh; Manisha Sonee; LeRoy Hall; Paul B Watkins; Heidrun Ellinger-Ziegelbauer; Alison H Harrill
Journal:  Toxicol Sci       Date:  2015-11-26       Impact factor: 4.849

Review 10.  Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?

Authors:  Mark A Febbraio; Saskia Reibe; Shabnam Shalapour; Geraldine J Ooi; Matthew J Watt; Michael Karin
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.